200 related articles for article (PubMed ID: 33147240)
21. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study.
Choun K; Decroo T; Mao TE; Lorent N; Gerstel L; Creswell J; Codlin AJ; Lynen L; Thai S
Glob Health Action; 2019; 12(1):1646024. PubMed ID: 31500551
[No Abstract] [Full Text] [Related]
22. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW
PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935
[TBL] [Abstract][Full Text] [Related]
23. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
[TBL] [Abstract][Full Text] [Related]
24. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
25. Microscopic observation drug-susceptibility assay vs. Xpert
Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of GeneXpert
Habous M; E Elimam MA; Kumar R; L Deesi ZA
Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
[TBL] [Abstract][Full Text] [Related]
27. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
Luetkemeyer AF; Firnhaber C; Kendall MA; Wu X; Mazurek GH; Benator DA; Arduino R; Fernandez M; Guy E; Johnson P; Metchock B; Sattler F; Telzak E; Wang YF; Weiner M; Swindells S; Sanne IM; Havlir DV; Grinsztejn B; Alland D;
Clin Infect Dis; 2016 May; 62(9):1081-8. PubMed ID: 26839383
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.
Henostroza G; Harris JB; Chitambi R; Siyambango M; Turnbull ER; Maggard KR; Krüüner A; Kapata N; Reid SE
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1033-9. PubMed ID: 27393536
[TBL] [Abstract][Full Text] [Related]
30. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
Tadesse M; Aragaw D; Rigouts L; Abebe G
Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
[TBL] [Abstract][Full Text] [Related]
31. [Incremental cost-effectiveness of the second Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis].
Wang SQ; Sun Q; Jiang GL; Fu YY; Shang YY; Huang HR; Wang GR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):432-437. PubMed ID: 31189229
[No Abstract] [Full Text] [Related]
32. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
Ozkutuk N; Surucüoglu S
Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
[TBL] [Abstract][Full Text] [Related]
33. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients With Suspected Pulmonary Tuberculosis.
Poonawala H; Leekha S; Medina-Moreno S; Filippell M; Johnson JK; Redfield RR; Saharia KK
Infect Control Hosp Epidemiol; 2018 May; 39(5):590-595. PubMed ID: 29582718
[TBL] [Abstract][Full Text] [Related]
34. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
Rice JP; Seifert M; Moser KS; Rodwell TC
PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
[TBL] [Abstract][Full Text] [Related]
35. Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert® MTB/RIF?
Mok Y; Tan TY; Tay TR; Wong HS; Tiew PY; Kam JW; Siao C
Int J Tuberc Lung Dis; 2016 May; 20(5):619-24. PubMed ID: 27084815
[TBL] [Abstract][Full Text] [Related]
36. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
[TBL] [Abstract][Full Text] [Related]
37. Integrating Xpert MTB/RIF for TB diagnosis in the private sector: evidence from large-scale pilots in Patna and Mumbai, India.
Deo S; Jindal P; Papineni S
BMC Infect Dis; 2021 Jan; 21(1):123. PubMed ID: 33509114
[TBL] [Abstract][Full Text] [Related]
38. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
[TBL] [Abstract][Full Text] [Related]
40. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
Opota O; Zakham F; Mazza-Stalder J; Nicod L; Greub G; Jaton K
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30541937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
